Survival for the entire cohort and causes of death
Kaplan-Meier estimated overall survival for the entire cohort at 36
months was 88.5% [95% CI 84-94]. Twenty-three (12.6%) patients
have died, with bacterial infections being responsible for 7 (30.4%)
deaths, fungal infections for 1 (4.3%), organ failures for 8 (34.8%),
recurrence of underlying disease for 3 (13.0%), secondary malignancy
for 1 (4.3%), while acute and chronic GVHD were responsible for 2
deaths (8.6%). For 1 patients (4.3%), the cause of death was unknown.